Executive Medical Director
Janssen Research & Development
Donne Bennett dL. Caces, MD, PhD, is a board-certified oncologist and hematologist, with both preclinical and clinical research expertise. He led multiple Phase 2/3 clinical trials and currently leading the Ibrutinib clinical development team at Janssen.
